Calreticulin exposure dictates the immunogenicity of cancer cell death

Nature Medicine

Volumn 13, Issue 1, 2007, Pages 54-61

  Obeid, Michel ^a,b,c   Tesniere, Antoine ^a,b,c   Ghiringhelli, François ^b,c,d   Fimia, Gian Maria ^e   Apetoh, Lionel ^b,c,d   Perfettini, Jean Luc ^a,b,c   Castedo, Maria ^a,b,c   Mignot, Grégoire ^b,c,d   Panaretakis, Theoharis ^a,b,c   Casares, Noelia ^a,b,c   Métivier, Didier ^a,b,c   Larochette, Nathanael ^a,b,c   Van Endert, Peter ^f,g   Ciccosanti, Fabiola ^e   Piacentini, Mauro ^e,h   Zitvogel, Laurence ^b,c,d   Kroemer, Guido ^a,b,c  

^a Institut Gustave Roussy   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

^e NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ARSENIC TRIOXIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETULIC ACID; BREFELDIN A; CALRETICULIN; CALYCULIN A; CAMPTOTHECIN; CERAMIDE; DOXORUBICIN; ETOPOSIDE; HOE 33342; IDARUBICIN; MITOMYCIN C; MITOXANTRONE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; RECOMBINANT CALRETICULIN; RECOMBINANT PROTEIN; SALUBRINAL; TAUTOMYCIN; THAPSIGARGIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; CANCER CELL; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SARCOMA;

ANIMALS; ANTHRACYCLINES; ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALRETICULIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; COLONIC NEOPLASMS; DENDRITIC CELLS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ETOPOSIDE; IMMUNOBLOTTING; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOMYCIN; NEOPLASMS, EXPERIMENTAL; PHAGOCYTOSIS; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; RNA INTERFERENCE;

EID: 33846057130     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1523     Document Type: Article

References (35)

1. Steinman, R.M. & Mellman, I. Immunotherapy bewitched, bothered, and bewildered no more. Science 305, 197-200 (2004).
2. Lake, R.A. & van der Most, R.G. A better way for a cancer cell to die. N. Engl. J. Med. 354, 2503-2504 (2006).
3. Zitvogel, L., Tesniere, A. & Kroemer, G. Cancer in spite of immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6, 715-727 (2006).
4. Zitvogel, L., Casares, N., Pequignot, M., Albert, M.L. & Kroemer, G. The immune response against dying tumor cells. Adv. Immunol. 84, 131-179 (2004).
5. Bellamy, C.O., Malcomson, R.D., Harrison, D.J. & Wyllie, A.H. Cell death in health and disease: the biology and regulation of apoptosis. Semin. Cancer Biol. 6, 3-16 (1995).
6. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462 (1995).
7. Igney, F.H. & Krammer, P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277-288 (2002).
8. Steinman, R.M., Turley, S., Mellman, I. & Inaba, K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416 (2000).
9. Liu, K. et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097 (2002).
10. Kroemer, G. et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 12, 1463-1467 (2005).
11. Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784-788 (2000).
12. Lauber, K., Blumenthal, S.G., Waibel, M. & Wesselborg, S. Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell 14, 277-287 (2004).
13. Yoshida, H. et al. Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells. Nature 437, 754-758 (2005).
14. Gardai, S.J. et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321-334 (2005).
15. Henson, P.M. & Hume, D.A. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27, 244-250 (2006).
16. Hanayama, R. et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304, 1147-1150 (2004).
17. Gaipl, U.S. et al. Inefficient clearance of dying cells and autoreactivity. Curr. Top. Microbiol. Immunol. 305, 161-176 (2006).
18. Vakkila, J. & Lotze, M.T. Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4, 641-648 (2004).
19. Casares, N. et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202, 1691-1701 (2005).
20. Blachere, N.E., Darnell, R.B. & Albert, M.L. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol. 3, e185 (2005).
21. Bedard, K., Szabo, E., Michalak, M. & Opas, M. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int. Rev. Cytol. 245, 91-121 (2005).
22. Ogden, C.A. et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781-795 (2001).
23. Jung, S. et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002).
24. Zhang, K. & Kaufman, R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J. Biol. Chem. 279, 25935-25938 (2004).
25. Gupta, V., Ogawa, A.K., Du, X., Houk, K.N. & Armstrong, R.W. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A. J. Med. Chem. 40, 3199-3206 (1997).
26. Boyce, M. et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935-939 (2005).
27. 2+-binding chaperone of the endoplasmic reticulum. Int. J. Biochem. Cell Biol. 37, 260-266 (2005).
28. Williams, D.B. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J. Cell Sci. 119, 615-623 (2006).
29. Kim, S.J., Park, K.M., Kim, N. & Yeom, Y.I. Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis. Biochem. Biophys. Res. Commun. 339, 463-468 (2006).
30. Hsieh, C.J. et al. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Vaccine 22, 3993-4001 (2004).
31. Cheng, W.F. et al. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity. Cancer Gene Ther. 13, 873-885 (2006).
32. Basu, S. & Srivastava, P.K. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med. 189, 797-802 (1999).
33. Basu, S., Binder, R.J., Suto, R., Anderson, K.M. & Srivastava, P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12, 1539-1546 (2000).
34. Zamzami, N. & Kroemer, G. Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis. Methods Mol. Biol. 282, 103-116 (2004).
35. Culina, S., Lauvau, G., Gubler, B. & van Endert, P.M. Calreticulin promotes folding of functional human leukocyte antigen class I molecules in vitro. J. Biol. Chem. 279, 54210-54215 (2004).